Govt testing each COVID vaccines for variants, looking at developing a pan-corona shot
Swarup also said that Biological E candidate may go to the regulator for approval by September-end and nasal vaccine given Phase 2-3 approval.
Aug 23, 2021, 15:59 PM IST
Promising new melanoma drug in the offing
The new compound, named SBI-756, targets a specific molecular machine known as the translation initiation complex.
Nov 26, 2015, 11:36 AM IST
IAVI and CureVac partner to accelerate development and testing of AIDS vaccine candidates
Researchers at IAVI's Neutralizing Antibody Center at The Scripps Research Institute and elsewhere have designed several novel immunogens that have the potential to elicit such antibodies.
Oct 16, 2015, 20:39 PM IST
